Biopharmaceutical companies’ commercial models must respond to an ever-changing marketplace, with increasing demands from both payers and patients for better care, improved outcomes, more affordable therapies, and increased speed to market.

In a recent interview, George Esgro, Vice President & Head, U.S. Commercial Solutions, Quintiles, discussed how strategic outsourcing can help companies deliver the necessary adaptability, flexibility and cost efficiencies.